Tuesday, October 15, 2019

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological Supplier MiMedx Group, Inc., a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA)...

Embrace® Active Scar Defense And Serena Williams Team Up To Talk About Motherhood, Healing...

Neodyne Biosciences, Inc. today announced they are partnering with professional tennis champion Serena Williams to raise awareness for its embrace® Active Scar Defense, an FDA cleared scar therapy system designed to prevent the formation of scar tissue...

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Havkin Urology in Florida

Havkin Urology is implementing a non-invasive and drug free solution for Erectile Dysfunction (ED) called GAINSWave, which boasts a 75% success rate. GAINSWave is a premium brand of shockwave therapy designed to remove micro-plaque and stimulate...

Enhanced Healthcare Partners Announces Investment in SCA Pharmaceuticals

Enhanced Healthcare Partners ("EHP"), a private equity firm focused exclusively on investing in the healthcare industry, has announced its investment in SCA Pharmaceuticals ("SCA"), a sterile compounding leader specializing in preparing sterile pharmaceuticals...

Autologous Stem Cell Therapy May Hold Key to Regeneration

USRM Chief Science Officer's Live Webinar Adds Voice to Debate U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the...

FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...

Virtual Reality in Medicine and Healthcare to Generate US$285 million in 2022

Therapy and Training Services have the highest opportunity in VR medical and healthcare segment Virtual Reality (VR) has brought a range of new services into the healthcare industry.  The immersive experience provided by VR...

New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions

New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth. Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...

Denteractive Launches 24/7 Live Online Dental Advice Service

Denteractive, an online teledentistry platform, launched a service that provides instant live professional responses to dental consumers. This service is available online 24/7, at all times of day and night. This allows people to receive advice...

Mylan Launches First AP-rated Generic Avelox® Injection

Mylan N.V. today announced the U.S. launch of Moxifloxacin Hydrochloride in 0.8% Sodium Chloride Injection, 400 mg/250 mL (1.6 mg/mL) in 250 mL single-dose flexible bags, the first AP-rated generic version of Bayer's...

Connect with us

4,472FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts